SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: vestor who wrote (79900)6/18/1999 1:10:00 PM
From: kendall harmon  Respond to of 119973
 
WTSLA, ARM, VSTR all at days highs



To: vestor who wrote (79900)6/18/1999 1:10:00 PM
From: judge  Read Replies (1) | Respond to of 119973
 
anybody else buying fncm at these levels .. bought yesterday and bought more today at 4 3/32.. curently trading at 4 3/32.. j



To: vestor who wrote (79900)6/21/1999 1:34:00 AM
From: blackjack17  Read Replies (1) | Respond to of 119973
 
Everyone knows that Premarin is the competition for Duramed's
new product Cenestin. Once the women of the world discover
several facts Cenestin should take a large percentage of
Premarin's market share. First is the fact that Premarin is made
from the urine of pregnant horses. The second is the fact that
these horses have in a lot of cases been treated inhumanely.
The following is excerpts from the book Natural Choices for
Menopause written by Maryilyn Glenville, Ph.D. "The horses are made to
spend six months is stalls with a harness type device attached to
their hindquarters to hold them in place. Often the stalls are too
small for the horses to lie down and inspectors from the world
society for the protection of animals found tethers that were so short
that the horses could not lay their heads on the ground. In all but
a few farms water was being restricted to ensure that the urine had
a high concentration of oestrogen. Adult horses were not the only ones
to suffer as thousands of foals born from the pregnant mares were
sold cheaply to be slaughtered" Once the women of the world are made
aware of this information I predict that Cenestin will control most
of the market. I therefore would rate this stock a strong buy as
the sales of Cenestin should reach way in excess of $100 Million
per year. Expect the stock to move strongly as the launch of this
product continues. Their first commercial shipments were actually made
on 5/12/99 and they will soon launch their national advertising.